DUAL TROPISM FOR MACROPHAGES AND LYMPHOCYTES TS A COMMON FEATURE OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 ISOLATES

被引:96
作者
VALENTIN, A
ALBERT, J
FENYO, EM
ASJO, B
机构
[1] KAROLINSKA INST,SWEDISH INST INFECT DIS CONTROL,DEPT CLIN VIROL,S-10521 STOCKHOLM,SWEDEN
[2] KAROLINSKA INST,DEPT VIROL,S-17177 STOCKHOLM,SWEDEN
关键词
D O I
10.1128/JVI.68.10.6684-6689.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have investigated the ability of human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates to infect and replicate in primary human macrophages. Monocytes from blood donors were allowed to differentiate into macrophages by culture in the presence of autologous lymphocytes and human serum for 5 days before infection. A panel of 70 HIV-1 and 12 HIV-2 isolates were recovered from seropositive individuals with different severities of HIV infection. A majority of isolates (55 HIV-1 and all HIV-2) were obtained from peripheral blood mononuclear cells, but isolates from cerebrospinal fluid, monocytes, brain tissue, plasma, and purified CD4(+) lymphocytes were also included. All isolates were able to infect monocyte-derived macrophages, even though the replicative capacity of the isolates varied. Interestingly, isolates with a rapid/high, syncytium-inducing phenotype did not differ from slow/low, non-syncytium-inducing isolates in their ability to replicate in monocyte-derived macrophages. Others have reported that rapid/high, syncytium-inducing isolates have a reduced ability to infect and replicate in monocytes. However, different methods to isolate and culture the monocytes/macrophages were used in these studies and our study. Thus, the ability of HIV isolates to replicate in monocytes/macrophages appears to be strongly influenced by the isolation and culture procedures. It remains to be determined which culture procedure is more relevant for the in vivo situation.
引用
收藏
页码:6684 / 6689
页数:6
相关论文
共 36 条
  • [1] ISOLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) FROM PLASMA DURING PRIMARY HIV-INFECTION
    ALBERT, J
    GAINES, H
    SONNERBORG, A
    NYSTROM, G
    PEHRSON, PO
    CHIODI, F
    VONSYDOW, M
    MOBERG, L
    LIDMAN, K
    CHRISTENSSON, B
    ASJO, B
    FENYO, EM
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) : 67 - 73
  • [2] REPLICATIVE CAPACITY OF HIV-2, LIKE HIV-1, CORRELATES WITH SEVERITY OF IMMUNODEFICIENCY
    ALBERT, J
    NAUCLER, A
    BOTTIGER, B
    BROLIDEN, PA
    ALBINO, P
    OUATTARA, SA
    BJORKEGREN, C
    VALENTIN, A
    BIBERFELD, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (04) : 291 - 295
  • [3] ASJO B, 1986, LANCET, V2, P660
  • [4] RELIABLE ISOLATION OF HUMAN IMMUNODEFICIENCY VIRUS FROM CULTURES OF NATURALLY INFECTED CD4+ T-CELLS
    BRINCHMANN, JE
    GAUDERNACK, G
    THORSBY, E
    JONASSEN, TO
    VARTDAL, F
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1989, 25 (03) : 293 - 300
  • [5] VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION
    CHENGMAYER, C
    QUIROGA, M
    TUNG, JW
    DINA, D
    LEVY, JA
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (09) : 4390 - 4398
  • [6] BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST
    CHENGMAYER, C
    SETO, D
    TATENO, M
    LEVY, JA
    [J]. SCIENCE, 1988, 240 (4848) : 80 - 82
  • [7] INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS
    CONNOR, RI
    MOHRI, H
    CAO, YZ
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (04) : 1772 - 1777
  • [8] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN SPINAL CORDS OF ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS WITH MYELOPATHY - EXPRESSION AND REPLICATION IN MACROPHAGES
    EILBOTT, DJ
    PERESS, N
    BURGER, H
    LANEVE, D
    ORENSTEIN, J
    GENDELMAN, HE
    SEIDMAN, R
    WEISER, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) : 3337 - 3341
  • [9] FENYO EM, 1988, J VIROL, V62, P4414
  • [10] FIORE J, IN PRESS VIROLOGY